HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
Clinical trial NCT01387932 · TERMINATED
Trial details
- NCT number
- NCT01387932
- Sponsor
- Merit Medical Systems, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2021-02-01
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.